Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment
antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.